Abstract
Hypercapnia-induced noncirrhotic hyperammonemia (HIH) presents a perplexing clinical scenario, challenging the conventional understanding of ammonia metabolism. Despite the well-established link between hyperammonemia and liver dysfunction, our recent observations revealed a novel association between hypercapnia and elevated ammonia levels in patients without chronic liver disease. This abstract encapsulates a brief report outlining five cases of HIH, shedding light on the pathophysiological mechanisms underlying this phenomenon and emphasizing the importance of heightened clinical awareness. This brief report elucidates the intricate interplay between respiratory and metabolic processes in the modulation of ammonia homeostasis. Ammonia, a neurotoxic metabolite primarily detoxified by hepatic mechanisms, has traditionally been associated with liver dysfunction. However, the emergence of HIH suggests alternative pathways influencing ammonia levels. The manuscript hypothesized possible mechanisms, and in addition, it explores the role of pulmonary vascular dynamics and congenital shunts in precipitating hyperammonemia in hypercapnic states. Recognition of this association not only prevents misdiagnosis of liver pathology but also informs targeted therapeutic interventions. Furthermore, the manuscript advocates for a paradigm shift in clinical practice, advocating for repeat ammonia measurements following the resolution of hypercapnia to ascertain the transient nature of hyperammonemia. While this report offers valuable insights into the enigmatic realm of HIH, it underscores the need for further research to elucidate the epidemiology, risk factors, and mechanistic underpinnings of this phenomenon. Future investigations could refine the mechanism and clinical significance of this association and ultimately optimize patient care in the context of hyperammonemia associated with hypercapnia.